Skip to main content
. 2016 Sep 1;7(40):65946–65956. doi: 10.18632/oncotarget.11779

Figure 1. c-Fos expression and cell viability were inhibited by ShRNA.

Figure 1

A. Western blot analysis performed on control vector and c-Fos shRNA using anti-c-Fos, and anti-α-tubulin antibodies. B. T98G glioma cell viability was inhibited by ShRNA1 and ShRNA2. *P<0.05; t-test. C. The viability of U251 glioma cells was inhibited by ShRNA1 and ShRNA2. *P<0.05; t-test.